ISSN 0918-6158
#Biosimilars #PharmaStrategy #MarketDynamics #MarketAccess #IndianPharma #LifeSciences #HealthcareStrategy To view or add a comment, sign in | & The Union Budget 2026 brings strong momentum for Indias pharma and biopharma ecosystemfocusing on affordability, innovation, and global alignment
That said, a few powerhouse ingredients can give you an edge on the GLP-1 production front, potentially leading to better results for your diet and weight, especially when taken together
Wegovy oral pill (daily tablet, weight management) An oral semaglutide pill for weight management reached the US market for the 2025 to 2026 period, the first oral GLP-1 approved for weight loss rather than diabetes
To identify beneficiaries with peripheral arterial disease (PAD), we used ICD-9 diagnosis codes for PAD identified by either Hirsh et al (August 2008) or Jaff et al (July 2010) in their analyses of peripheral arterial disease among Medicare beneficiaries
Hetal Gor at Better U Medical Spa in the Hoboken area